Stephen Tomlinson to Drug Design
This is a "connection" page, showing publications Stephen Tomlinson has written about Drug Design.
Connection Strength
0.111
-
CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation. Adv Exp Med Biol. 2013; 735:137-54.
Score: 0.097
-
Complement function in mAb-mediated cancer immunotherapy. Trends Immunol. 2004 Mar; 25(3):158-64.
Score: 0.013